These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 28160567

  • 21. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
    Li Y, Li X, Fan G, Fukushi J, Matsumoto Y, Iwamoto Y, Zhu Y.
    Cancer Lett; 2012 Jul 01; 320(1):14-22. PubMed ID: 22266186
    [Abstract] [Full Text] [Related]

  • 22. USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth.
    Gierisch ME, Pedot G, Walser F, Lopez-Garcia LA, Jaaks P, Niggli FK, Schäfer BW.
    Sci Rep; 2019 Jan 30; 9(1):951. PubMed ID: 30700749
    [Abstract] [Full Text] [Related]

  • 23. Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
    Ju HQ, Zhuang ZN, Li H, Tian T, Lu YX, Fan XQ, Zhou HJ, Mo HY, Sheng H, Chiao PJ, Xu RH.
    Cancer Lett; 2016 Aug 28; 379(1):1-11. PubMed ID: 27233476
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
    Tan B, Dong S, Shepard RL, Kays L, Roth KD, Geeganage S, Kuo MS, Zhao G.
    J Biol Chem; 2015 Jun 19; 290(25):15812-15824. PubMed ID: 25944913
    [Abstract] [Full Text] [Related]

  • 25. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
    El Beaino M, Liu J, Wasylishen AR, Pourebrahim R, Migut A, Bessellieu BJ, Huang K, Lin PP.
    BMC Cancer; 2020 Jan 02; 20(1):3. PubMed ID: 31898537
    [Abstract] [Full Text] [Related]

  • 26. Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.
    Stoll G, Surdez D, Tirode F, Laud K, Barillot E, Zinovyev A, Delattre O.
    Nucleic Acids Res; 2013 Oct 02; 41(19):8853-71. PubMed ID: 23935076
    [Abstract] [Full Text] [Related]

  • 27. Participation of nuclear localization signal 2 in the 3'-ETS domain of FLI1 in nuclear translocation of various chimeric EWS-FLI1 oncoproteins in Ewing tumor.
    Honsei N, Ikuta T, Kawana K, Kaneko Y, Kawajiri K.
    Int J Oncol; 2006 Sep 02; 29(3):689-93. PubMed ID: 16865286
    [Abstract] [Full Text] [Related]

  • 28. CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
    Sun H, Lin DC, Cao Q, Guo X, Marijon H, Zhao Z, Gery S, Xu L, Yang H, Pang B, Lee VK, Lim HJ, Doan N, Said JW, Chu P, Mayakonda A, Thomas T, Forscher C, Baloglu E, Shacham S, Rajalingam R, Koeffler HP.
    Cancer Res; 2016 May 01; 76(9):2687-97. PubMed ID: 26956669
    [Abstract] [Full Text] [Related]

  • 29. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C, Lamoureux F, Baud'huin M, Rodriguez Calleja L, Quillard T, Amiaud J, Tirode F, Rédini F, Bradner JE, Heymann D, Ory B.
    Oncotarget; 2016 Apr 26; 7(17):24125-40. PubMed ID: 27006472
    [Abstract] [Full Text] [Related]

  • 30. EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.
    Tanner JM, Bensard C, Wei P, Krah NM, Schell JC, Gardiner J, Schiffman J, Lessnick SL, Rutter J.
    Mol Cancer Res; 2017 Nov 26; 15(11):1517-1530. PubMed ID: 28720588
    [Abstract] [Full Text] [Related]

  • 31. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.
    Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ.
    Neoplasia; 2011 Feb 26; 13(2):145-53. PubMed ID: 21403840
    [Abstract] [Full Text] [Related]

  • 32. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells.
    Schuster S, Penke M, Gorski T, Gebhardt R, Weiss TS, Kiess W, Garten A.
    Biochem Biophys Res Commun; 2015 Mar 06; 458(2):334-40. PubMed ID: 25656579
    [Abstract] [Full Text] [Related]

  • 33. Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition.
    Cea M, Cagnetta A, Fulciniti M, Tai YT, Hideshima T, Chauhan D, Roccaro A, Sacco A, Calimeri T, Cottini F, Jakubikova J, Kong SY, Patrone F, Nencioni A, Gobbi M, Richardson P, Munshi N, Anderson KC.
    Blood; 2012 Oct 25; 120(17):3519-29. PubMed ID: 22955917
    [Abstract] [Full Text] [Related]

  • 34. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
    Saulnier O, Guedri-Idjouadiene K, Aynaud MM, Chakraborty A, Bruyr J, Pineau J, O'Grady T, Mirabeau O, Grossetête S, Galvan B, Claes M, Al Oula Hassoun Z, Sadacca B, Laud K, Zaïdi S, Surdez D, Baulande S, Rambout X, Tirode F, Dutertre M, Delattre O, Dequiedt F.
    Nucleic Acids Res; 2021 May 21; 49(9):5038-5056. PubMed ID: 34009296
    [Abstract] [Full Text] [Related]

  • 35. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
    Boro A, Prêtre K, Rechfeld F, Thalhammer V, Oesch S, Wachtel M, Schäfer BW, Niggli FK.
    Int J Cancer; 2012 Nov 01; 131(9):2153-64. PubMed ID: 22323082
    [Abstract] [Full Text] [Related]

  • 36. RETRACTED: Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
    Lee HJ, Yoon C, Schmidt B, Park DJ, Zhang AY, Erkizan HV, Toretsky JA, Kirsch DG, Yoon SS.
    Mol Cancer Ther; 2013 Nov 01; 12(11):2591-600. PubMed ID: 23966622
    [Abstract] [Full Text] [Related]

  • 37. Mithramycin A Radiosensitizes EWS:Fli1+ Ewing Sarcoma Cells by Inhibiting Double Strand Break Repair.
    Lin MY, Damron TA, Oest ME, Horton JA.
    Int J Radiat Oncol Biol Phys; 2021 Apr 01; 109(5):1454-1471. PubMed ID: 33373655
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization.
    Pedot G, Marques JG, Ambühl PP, Wachtel M, Kasper S, Ngo QA, Niggli FK, Schäfer BW.
    Neoplasia; 2022 May 01; 27():100784. PubMed ID: 35366465
    [Abstract] [Full Text] [Related]

  • 39. Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor.
    Osgood CL, Maloney N, Kidd CG, Kitchen-Goosen S, Segars L, Gebregiorgis M, Woldemichael GM, He M, Sankar S, Lessnick SL, Kang M, Smith M, Turner L, Madaj ZB, Winn ME, Núñez LE, González-Sabín J, Helman LJ, Morís F, Grohar PJ.
    Clin Cancer Res; 2016 Aug 15; 22(16):4105-18. PubMed ID: 26979396
    [Abstract] [Full Text] [Related]

  • 40. Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.
    Herrero-Martín D, Osuna D, Ordóñez JL, Sevillano V, Martins AS, Mackintosh C, Campos M, Madoz-Gúrpide J, Otero-Motta AP, Caballero G, Amaral AT, Wai DH, Braun Y, Eisenacher M, Schaefer KL, Poremba C, de Alava E.
    Br J Cancer; 2009 Jul 07; 101(1):80-90. PubMed ID: 19491900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.